{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:26:07Z","timestamp":1751538367518,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Henan Programs for Medical Science and Technology Development","award":["LHGJ20190208"],"award-info":[{"award-number":["LHGJ20190208"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["Young Scientist Fund","212300410267"],"award-info":[{"award-number":["Young Scientist Fund","212300410267"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Program of China\u2019s National Health Commission (NHC) and Henan Province","award":["Young Scientist Fund","SBGJ202303033"],"award-info":[{"award-number":["Young Scientist Fund","SBGJ202303033"]}]},{"name":"Key Research Projects of Henan Higher Education Institutions","award":["23A320021"],"award-info":[{"award-number":["23A320021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03621-2","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T18:19:04Z","timestamp":1722363544000},"page":"507-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PSIP1 promotes gefitinib resistance in lung adenocarcinoma by inducing the expression of WASF3 and its downstream ITGB3\/AKT signaling"],"prefix":"10.1007","volume":"27","author":[{"given":"Shujun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9675-2515","authenticated-orcid":false,"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"3621_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"3621_CR2","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/cancers14071759","volume":"14","author":"L Seguin","year":"2022","unstructured":"Seguin L, Durandy M, Feral CC. Lung adenocarcinoma tumor origin: a guide for personalized medicine. Cancers (Basel). 2022;14:1759.","journal-title":"Cancers (Basel)"},{"key":"3621_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/cancers13030384","volume":"13","author":"M Spella","year":"2021","unstructured":"Spella M, Stathopoulos GT. Immune resistance in lung adenocarcinoma. Cancers (Basel). 2021;13:384.","journal-title":"Cancers (Basel)"},{"key":"3621_CR4","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1158\/1078-0432.CCR-14-2748","volume":"21","author":"K Politi","year":"2015","unstructured":"Politi K, Herbst RS. Lung cancer in the era of precision medicine. Clin Cancer Res. 2015;21:2213\u201320.","journal-title":"Clin Cancer Res"},{"key":"3621_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-022-01547-3","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, Wang K, Wang X, Jia Z, Yang Y, Duan Y, et al. Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERR\u03b1 re-expression. Mol Cancer. 2022;21:77.","journal-title":"Mol Cancer"},{"key":"3621_CR6","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1200\/JCO.2010.31.8923","volume":"29","author":"VL Keedy","year":"2011","unstructured":"Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, et al. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol. 2011;29:2121\u20137.","journal-title":"J Clin Oncol"},{"key":"3621_CR7","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1158\/1078-0432.CCR-07-2248","volume":"14","author":"JA Engelman","year":"2008","unstructured":"Engelman JA, J\u00e4nne PA. Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Clin Cancer Res. 2008;14:2895\u20139.","journal-title":"Clin Cancer Res"},{"key":"3621_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S1568-9972(03)00063-6","volume":"2","author":"V Ganapathy","year":"2003","unstructured":"Ganapathy V, Daniels T, Casiano CA. LEDGF\/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis. Autoimmun Rev. 2003;2:290\u20137.","journal-title":"Autoimmun Rev"},{"key":"3621_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2019.11.026","volume":"225","author":"L Pei","year":"2020","unstructured":"Pei L, Liu H, Ouyang S, Zhao Q, Li X, Bi J, et al. Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer. Immunobiology. 2020;225: 151891.","journal-title":"Immunobiology"},{"key":"3621_CR10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/carcin\/bgx062","volume":"38","author":"DK Singh","year":"2017","unstructured":"Singh DK, Gholamalamdari O, Jadaliha M, Li XL, Lin YC, Zhang Y, et al. PSIP1\/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes. Carcinogenesis. 2017;38:966\u201375.","journal-title":"Carcinogenesis"},{"key":"3621_CR11","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.3390\/cells10102723","volume":"10","author":"GL Ortiz-Hernandez","year":"2021","unstructured":"Ortiz-Hernandez GL, Sanchez-Hernandez ES, Ochoa PT, Elix CC, Alkashgari HR, McMullen JRW, et al. The LEDGF\/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells. Cells. 2021;10:2723.","journal-title":"Cells"},{"key":"3621_CR12","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.ajpath.2019.08.012","volume":"189","author":"H Qin","year":"2019","unstructured":"Qin H, Lu S, Thangaraju M, Cowell JK. Wasf3 deficiency reveals involvement in metastasis in a mouse model of breast cancer. Am J Pathol. 2019;189:2450\u20138.","journal-title":"Am J Pathol"},{"key":"3621_CR13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3892\/ol.2014.2276","volume":"8","author":"J Wu","year":"2014","unstructured":"Wu J, Wang GC, Chen XJ, Xue ZR. Expression of WASF3 in patients with non-small cell lung cancer: correlation with clinicopathological features and prognosis. Oncol Lett. 2014;8:1169\u201374.","journal-title":"Oncol Lett"},{"key":"3621_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13058-023-01634-3","volume":"25","author":"W Wang","year":"2023","unstructured":"Wang W, Rana PS, Markovic V, Sossey-Alaoui K. The WAVE3\/\u03b2-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer. Breast Cancer Res. 2023;25:31.","journal-title":"Breast Cancer Res"},{"key":"3621_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/bjc.1991.7","volume":"63","author":"K Snow","year":"1991","unstructured":"Snow K, Judd W. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines. Br J Cancer. 1991;63:17\u201328.","journal-title":"Br J Cancer"},{"key":"3621_CR16","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1158\/1535-7163.MCT-19-0181","volume":"18","author":"C Wang","year":"2019","unstructured":"Wang C, Wang T, Lv D, Li L, Yue J, Chen H-Z, et al. Acquired resistance to EGFR TKIs mediated by TGF\u03b21\/Integrin \u03b23 signaling in EGFR-mutant lung cancer. Mol Cancer Ther. 2019;18:2357\u201367.","journal-title":"Mol Cancer Ther"},{"key":"3621_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13045-020-01009-7","volume":"13","author":"Y Fu","year":"2020","unstructured":"Fu Y, Zhang Y, Lei Z, Liu T, Cai T, Wang A, et al. Abnormally activated OPN\/integrin \u03b1V\u03b23\/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. J Hematol Oncol. 2020;13:169.","journal-title":"J Hematol Oncol"},{"key":"3621_CR18","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/ijms22020836","volume":"22","author":"R Loveless","year":"2021","unstructured":"Loveless R, Teng Y. Targeting WASF3 signaling in metastatic cancer. Int J Mol Sci. 2021;22:836.","journal-title":"Int J Mol Sci"},{"key":"3621_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.197956","volume":"282","author":"C Yang","year":"2020","unstructured":"Yang C, Lan R, Wang X, Zhao Q, Li X, Bi J, et al. Integrin \u03b23, a RACK1 interacting protein, is critical for porcine reproductive and respiratory syndrome virus infection and NF-\u03baB activation in Marc-145 cells. Virus Res. 2020;282: 197956.","journal-title":"Virus Res"},{"key":"3621_CR20","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1002\/ijc.28594","volume":"134","author":"V Jeannot","year":"2014","unstructured":"Jeannot V, Busser B, Brambilla E, Wislez M, Robin B, Cadranel J, et al. The PI3K\/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism. Int J Cancer. 2014;134:2560\u201371.","journal-title":"Int J Cancer"},{"key":"3621_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s13402-020-00556-y","volume":"44","author":"L Lou","year":"2021","unstructured":"Lou L, Wang J, Lv F, Wang G, Li Y, Xing L, et al. Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP). Cell Oncol (Dordr). 2021;44:109\u201333.","journal-title":"Cell Oncol (Dordr)"},{"key":"3621_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s10020-022-00547-9","volume":"28","author":"H Li","year":"2022","unstructured":"Li H, Song D, Liu Q, Li L, Sun X, Guo J, et al. miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3\/PIK3R1\/Akt pathway and induces endothelial cell injury and lipid accumulation. Mol Med. 2022;28:120.","journal-title":"Mol Med"},{"key":"3621_CR23","doi-asserted-by":"publisher","first-page":"eaaz8411","DOI":"10.1126\/sciadv.aaz8411","volume":"6","author":"R Gao","year":"2020","unstructured":"Gao R, Bao J, Yan H, Xie L, Qin W, Ning H, et al. Competition between PAF1 and MLL1\/COMPASS confers the opposing function of LEDGF\/p75 in HIV latency and proviral reactivation. Sci Adv. 2020;6:eaaz8411.","journal-title":"Sci Adv"},{"key":"3621_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/ijms22020792","volume":"22","author":"T Ohmori","year":"2021","unstructured":"Ohmori T, Yamaoka T, Ando K, Kusumoto S, Kishino Y, Manabe R, et al. Molecular and clinical features of EGFR-TKI-associated lung injury. Int J Mol Sci. 2021;22:792.","journal-title":"Int J Mol Sci"},{"key":"3621_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/1759-7714.12171","volume":"6","author":"H Choi","year":"2015","unstructured":"Choi H, Chang J, Shin HJ, Park C-K, Oh I-J, Kim K-S, et al. Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma. Thorac Cancer. 2015;6:224\u20136.","journal-title":"Thorac Cancer"},{"key":"3621_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030132","volume":"7","author":"A Basu","year":"2012","unstructured":"Basu A, Rojas H, Banerjee H, Cabrera IB, Perez KY, De Le\u00f3n M, et al. Expression of the stress response oncoprotein LEDGF\/p75 in human cancer: a study of 21 tumor types. PLoS ONE. 2012;7: e30132.","journal-title":"PLoS ONE"},{"key":"3621_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41417-021-00319-3","volume":"29","author":"A Canella","year":"2022","unstructured":"Canella A, Van Belle S, Brouns T, Nigita G, Carlon MS, Christ F, et al. LEDGF\/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators. Cancer Gene Ther. 2022;29:133\u201340.","journal-title":"Cancer Gene Ther"},{"key":"3621_CR28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1158\/0008-5472.CAN-15-1680","volume":"76","author":"Y Teng","year":"2016","unstructured":"Teng Y, Bahassan A, Dong D, Hanold LE, Ren X, Kennedy EJ, et al. Targeting the WASF3-CYFIP1 complex using stapled peptides suppresses cancer cell invasion. Cancer Res. 2016;76:965\u201373.","journal-title":"Cancer Res"},{"key":"3621_CR29","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.14423","volume":"111","author":"N Shibuya","year":"2020","unstructured":"Shibuya N, Kakeji Y, Shimono Y. MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer. Cancer Sci. 2020;111:2093\u2013103.","journal-title":"Cancer Sci"},{"key":"3621_CR30","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jcb.26334","volume":"119","author":"J Wang","year":"2018","unstructured":"Wang J, Feng Y, Chen X, Du Z, Jiang S, Ma S, et al. SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin. J Cell Biochem. 2018;119:1733\u201345.","journal-title":"J Cell Biochem"},{"key":"3621_CR31","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.1038\/s41598-023-35743-y","volume":"13","author":"H Yu","year":"2023","unstructured":"Yu H, Zhang W, Xu XR, Chen S. Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironment. Sci Rep. 2023;13:9682.","journal-title":"Sci Rep"},{"key":"3621_CR32","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.7150\/jca.66126","volume":"13","author":"J Ding","year":"2022","unstructured":"Ding J, Ding X, Leng Z. LPCAT1 promotes gefitinib resistance via upregulation of the EGFR\/PI3K\/AKT signaling pathway in lung adenocarcinoma. J Cancer. 2022;13:1837\u201347.","journal-title":"J Cancer"},{"key":"3621_CR33","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.1093\/emboj\/17.22.6723","volume":"17","author":"H Ge","year":"1998","unstructured":"Ge H, Si Y, Roeder RG. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. Embo J. 1998;17:6723\u20139.","journal-title":"Embo J"},{"key":"3621_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0092-8674(94)90428-6","volume":"78","author":"H Ge","year":"1994","unstructured":"Ge H, Roeder RG. Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell. 1994;78:513\u201323.","journal-title":"Cell"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03621-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T16:21:44Z","timestamp":1738254104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03621-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["3621"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03621-2","relation":{},"ISSN":["1699-3055"],"issn-type":[{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving animal experiments were performed with consent from the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval No. 2024-KY-0567\u2013001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have read the paper and agree that it can be published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed Consent is not required for this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}